FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 312:1594-1599 June 20, 1985 Number 25 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We developed a radioimmunoassay to measure the attack complex of complement (SC5b-9) in serum from patients with systemic lupus erythematosus. The radioimmunoassay used a monoclonal antibody to an antigen of C9, which is absent from native C9 but present on SC5b-9. SC5b-9 was detectable in 13 of 63 normal subjects, with a mean value of 0.5 unit (range, 0 to 4.8), and elevated in 13 of 14 patients with active lupus. Analysis of 108 samples from the patients with lupus revealed a mean value of 10.1 units (range, 0 to 35) when the disease was active and 1.0 unit (range, 0 to 433) when it was clinically stable. SC5b-9 was a more sensitive measure of disease activity than C3, C4, or CH50; its specificity was equivalent to that of C3 and C4. SC5b-9 was elevated in serum from 6 of 49 patients with other forms of glomerulonephritis. Our study documents the presence of SC5b-9 in abnormal serum and correlates its elevation with clinical disease activity in patients with active systemic lupus erythematosus.

This article has been cited by other articles:

• Ekdahl, K. N., Norberg, D., Bengtsson, A. A., Sturfelt, G., Nilsson, U. R., Nilsson, B. (2007). Use of Serum or Buffer-Changed EDTA-Plasma in a Rapid, Inexpensive, and Easy-To-Perform Hemolytic Complement Assay for Differential Diagnosis of Systemic Lupus Erythematosus and Monitoring of Patients with the Disease. CVI 14: 549-555 [Abstract] [Full Text]  
• Manzi, S, Ahearn, J M, Salmon, J (2004). New insights into complement: a mediator of injury and marker of disease activity in systemic lupus erythematosus. Lupus 13: 298-303 [Abstract]  
• Dobrina, A., Pausa, M., Fischetti, F., Bulla, R., Vecile, E., Ferrero, E., Mantovani, A., Tedesco, F. (2002). Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo. Blood 99: 185-192 [Abstract] [Full Text]  
• Keane, M. P, Lynch, J. P III (2000). Rare diseases bullet 7: Pleuropulmonary manifestations of systemic lupus erythematosus. Thorax 55: 159-166 [Full Text]  
• Tedesco, F., Pausa, M., Nardon, E., Introna, M., Mantovani, A., Dobrina, A. (1997). The Cytolytically Inactive Terminal Complement Complex Activates Endothelial Cells to Express Adhesion Molecules and Tissue Factor Procoagulant Activity. JEM 185: 1619-1628 [Abstract] [Full Text]  
• Griggs, R. C., Karpati, G. (1991). The Pathogenesis of Dermatomyositis. Arch Neurol 48: 21-22 [Abstract]